All the patients who presented to Manmohan Cardiothoracic Vascular and transplant center and were diagnosed to have pericardial effusion (small/ moderate/ large Abstract Background and Aims: Tuberculosis remains an important etiological cause of pericarditis and pericardial effusion in developing countries like Nepal. The objective of this study is to identify the various presentations of tuberculous pericarditis along with the demographic profile in our context and their short term outcome.
Introduction
The World Health Organization (WHO) estimates that each year more than 8 million new cases of tuberculosis occur and approximately 3 million persons die from it, most occurring in developing countries due to homelessness, malnourishment, and over crowdedness, and where human immunodeficiency virus (HIV) infection may be common. 1 However, there has been a significant decline in tuberculosis in industrialized countries over the past 100 years. 2 Tuberculous Pericarditis, one of the manifestation of Mycobacterium tuberculosis infection, is found in approximately 1% of all autopsied cases of tuberculosis and in 1% to 2% of instances of pulmonary TB. 3 Tuberculous pericarditis presents clinically in 3 forms i.e. pericardial effusion, constrictive pericarditis, and a combination of effusion and constriction. 3 A "definite" diagnosis of tuberculous pericarditis in tuberculosis endemic countries is based on the demonstration of tubercle bacilli in pericardial fluid or on a histological section of the pericardium; "probable" tuberculous pericarditis is based on the proof of tuberculosis elsewhere in a patient with otherwise unexplained pericarditis, a lymphocytic pericardial exudate with raised adenosine deaminase(ADA) levels, and/or appropriate response to a trial of antituberculosis chemotherapy. 3 Tuberculosis (TB) is responsible for about 4% of cases of acute pericarditis, 7% of cases of cardiac tamponade and about 6% of cases of constrictive pericarditis in the developed countries however in the underdeveloped countries, TB is the leading cause of pericarditis. 4 It leads to a mortality of 17% to 40% so that early diagnosis and institution of appropriate therapy are critical to prevent mortality. 3 Despite prompt anti tubercular treatment and use of corticosteroids, constrictive pericarditis is one of the most serious sequelae of TB pericarditis and occurs in 30% to 60% of these patients. Tuberculosis as an etiology of constrictive pericarditis is more common than other causes in Africa and Asia. 
Methodology:
Nepalese Heart Journal 2018; 15(1): 35-38 whether with or without tamponade) or chronic constrictive pericarditis of tubercular origin between September 2015 and August 2017 were included. Patients of any age or gender were taken. Detailed history about fever, shortness of breath, orthopnea, cough, chest pain, leg swelling or abdominal distension was inquired with clinical evaluation such as jugular venous distension, pericardial rub or distant heart sounds were mentioned. ECG, chest x-ray, 2D echocardiography (GE, Vivid 7) along with baseline blood investigations were sent.
The size of pericardial effusion was measured during diastole. The pericardial effusion was classified as small (<10mm), moderate (10-20mm ) and large (>20mm). The cardiac tamponade was diagnosed by presence of large pericardial effusion with swinging heart, diastolic collapse of right atrium and right ventricle, variations in E velocities during respiration across the mitral valve, tricuspid valve and pulmonary outflow that are greater than 25, 50 and 30% and Inferior Venacava (IVC) plethora (dilatation >20mm and <50% reduction in diameter of IVC with respiratory phases). The constrictive pericarditis was diagnosed by biatrial enlargement, ventricular septal shift/ shudder, prominent diastolic flow reversals in hepatic vein in expiration, preserved or elevated e', annulus reversus, annulus paradoxus, respiratory variation in mitral inflow velocity, plethora of IVC, pericardial thickening, distortion of ventricular contour, pericardial effusion if effusive-constrictive pericarditis. Chronic constrictive pericarditis was confirmed by CECT chest showing thickened and calcified pericardium as well as dilated suprahepatic inferior venacava.
Those patients who were in cardiac tamponade or large pericardial effusion whose diagnosis was in dilemma underwent pericardiocentesis under fluoroscopic guidance or pericardial window made (if pericardiocentesis was not feasible). Some patients had pericardial biopsy when pericardial window was made. The pericardial fluid was sent for cytology (total white cell count, differential count), biochemistry [protein, lactate dehydrogenase (LDH), Adenosine deaminase (ADA), sugar], microbiology [Acid Fast Bacilli (AFB) stain, culture, gram stain] as well as for malignant cell cytology. In addition, patients underwent tests for HIV, Hepatitis B and C, blood biochemistry, Rheumatoid factor (RF), Anti Nuclear Antibody (ANA), Thyroid Function Test (TFT), Erythrocyte Sedimentation Rate (ESR), C-reactive protein (CRP), sputum for AFB stain, gram stain and culture. The cut-off point for ADA of pericardial fluid and pleural fluid to be positive was taken as ≥40U/L for diagnosis of tuberculosis. Tuberculin Skin Test was also done and categorized as per Centers for Disease Control and prevention. An induration of 5 or more millimeters is considered positive in -HIV-infected persons, a recent contact of a person with TB disease, persons with fibrotic changes on chest radiograph consistent with prior TB, persons who are immunosuppressed, 10 or more millimeters considered positive in recent immigrants (< 5 years) from high-prevalence countries, injection drug users, children < 4 years of age, infants, children, and adolescents exposed to adults in high-risk categories and an induration of 15 or more millimeters is considered positive in any person with no known risk factors for TB.
When the effusion was small to moderate, the diagnosis of tuberculosis was supported by finding the tubercular lesion elsewhere in the body or other supportive investigations for example pleural fluid analysis instead of pericardial fluid analysis if they had coexisting pleural effusion where the cutoff value of ADA was taken ≥40U/L to diagnose tubercular pleural effusion. When the diagnostic dilemma occurred, a trial of anti tubercular drugs along with steroids were given and the response was observed by regular follow up of the patient until resolved after which they were enrolled in the study. Those patients were excluded whose effusion didn't resolve after the course of anti-tubercular medications. All those patients with chronic constrictive pericarditis were enrolled who were documented to have tuberculous pericardial effusion in the past. The patients who had other causes of pericardial effusion were excluded such as deranged thyroid function, connective tissue disorder or malignancy found elsewhere in the body or positive malignant cells in pericardial fluid and in whom no evidence of tuberculosis was detected for 6 months after initial presentation.
Result:
During the study period, 53 patients were included of whom 62% were male and 38% were female patients. The ages ranged from 6-71years (42±19.5). (Figure 1 ) The most common manifestation seen was large pericardial effusion (30%) followed by CCP (22.6%), 19% presented in cardiac tamponade, others were pyopericardium, perimyocarditis and acute pericarditis. liter. Echocardiography of thirty-one patients (60%) had fibrin strands crisscrossing the pericardial space. Ten patients (20%) had associated pleural effusion and one patient had loculated empyema thoracis. Pericardiocentesis was done in 20 patients with large pericardial effusion who had or developed cardiac tamponade. ADA of the pleural fluid or pericardial fluid whichever was available supported for tubercular effusion. The ADA was positive in 75% of the cases when pericardial fluid was analyzed whereas it was positive in only 40% of the cases when pleural fluid was analyzed. The fluids had lymphocytic predominance in most i.e. 81% in pericardial fluid and 90% in pleural fluid. The Absolute Lymphocyte Count (ALC) of pericardial fluid was high with mean of 2855 cells/mm 3 . Pericardial biopsy was taken when pericardial window was made in 2 patients with large pericardial effusion but showed non-specific chronic inflammation. The tuberculin skin test was done in all patients and measured 2-26mm and it was positive (≥10mm) in 18% of the cases where it supported the diagnosis when the body fluid wasn't available for analysis specially with small to moderate pericardial effusion. Chest pain 7
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The patients were given anti tubercular treatment (ATT) including isoniazid, rifampicin, pyrazinamide and ethambutol as well as prednisolone as per national guideline who were diagnostically proven and those who didn't have confirmatory evidence of tuberculosis. The patients were followed up till the completion of ATT with echocardiography. The pericardial effusion had resolved in most patients and was thus included in this study. However, two of the patients with cardiac tamponade developed CCP on follow up after 3 and 4 months. The patients with CCP initially diagnosed at presentation had undergone pericardiectomy after 4-6 weeks of antitubercular treatment. There was one case with seropositivity for Hepatitis B and one positive for Human Immunodeficiency Virus (HIV). Two patients died of whom one was case of CCP due to decompensated heart failure and other case was HIV seropositive with chronic kidney disease in cardiac tamponade whose pericardiocentesis was done but the patient succumbed due to cardiac arrest secondary to refractory hyperkalemia.
Discussion:
The awareness of tuberculosis as the possible cause of a pericardial effusion often depends on the frequency with which tuberculosis is encountered in practice. 6 Tuberculous pericarditis is common in all age groups with varying features like fever, dyspnea, chest pain, abdominal distension and leg swelling. Reuter et al studied 233 cases of pericardial effusion that showed that fever, night sweats, weight loss, and peripheral blood leukocyte count (<10 x 10 9 /l) were independently predictive of tuberculous pericarditis. Pericardial fluid ADA ≥40 U/l had 87% sensitivity and 89% specificity. 7 Our study also showed the usefulness of basic diagnostic tools to assist clinical decision-making especially in poor resource countries like ours for instance, raised pericardial fluid ADA has been the major evidence for diagnosing tuberculous pericarditis and similar to this study the mean peripheral blood leukocyte count was 7.8x10 9 /liter. ADA is a valuable marker with both high sensitivity and specificity in the diagnosis of tuberculous pericarditis but with relative sensitivity and specificity for the diagnosis of tuberculous pleurisy. 8, 9 In a metaanalysis of 11 studies, 938 subjects were included which showed the sensitivity of ADA as 0.90 and specificity as 0.86. 8 In our study also ADA remained as a valuable marker for tubercular pericardial effusion than tubercular pleural effusion.
Mutyaba et al had mentioned from his review article that was retrieved from sub-Saharan Africa and Asia that among the 3 predominant clinical manifestations of tuberculous heart disease, the most frequent is TB pericarditis followed by myocardial TB with or without aneurysm formation, and TB aortitis with or without mycotic aneurysms and pseudoaneurysms involving the aortic valve and/or sinuses of Valsalva. In the developing world, 40% to 70% of large pericardial effusions are tuberculous in origin whereas in the developed world, less than 4% of cases are tuberculous. 10 Tuberculous myocarditis showed to be a rare manifestation of cardiovascular TB with an occurrence rate of 0.14% in more than 13,000 autopsies performed over 27 years by Rose and colleagues. 11 Tuberculous infection of the aorta seemed to be an exceedingly rare manifestation of TB with an occurrence rate of 0.004% in 22,792 postmortems examinations over 50 years. 10 In our study also the most common cardiac manifestation of tuberculosis seen was tuberculous pericarditis in the form of large pericardial effusion (30%) followed by CCP (22.6%), 19% presented in cardiac tamponade, others were pyopericardium, perimyocarditis and acute pericarditis. However the rarer manifestations of tuberculosis as found in other studies were not found in this study.
Tuberculous pericarditis is the commonest manifestation of TB in the cardiovascular system, and pericardial constriction is dreaded sequelae, occurring in approximately 8% of affected individuals despite effective anti-TB therapy. 12 TB is, by far, the most common cause of pericardial constriction in the developing world, accounting for about 40-90% of cases seen in different series. 13 By contrast, less than 5% of cases of pericardial constriction in the developed world are attributable to TB. 14 Cherian et al in his review article has suggested the criteria for diagnosis of tuberculous etiology of pericardial effusion: Invasive criteria was culture of Mycobacterium tuberculosis from pericardial fluid or tissue, pericardial tuberculous granuloma with acid-fast bacilli, pericardial tuberculous granuloma with positive tuberculin skin test, tuberculous granuloma in scalene node or peripheral lymph node or pleura with positive tuberculin test. Non-invasive criteria was active tuberculosis elsewhere in the body and response to specific antitubercular therapy. 15 In our study, the noninvasive criteria and indirect evidences typically became more practical and valuable.
Echocardiography is the definitive investigation for pericardial effusion and tamponade, particularly valuable for distinguishing effusion from subacute constriction. 16, 17 Cherian et al did a study where the patients with tubercular pericardial effusion pericardial deposits and strands in pericardial space on echocardiography and 31% of patients had positive culture for M. tuberculosis from pericardial fluid or biopsy. 18 Through echocardiography we found fibrinous strands and pericardial thickening suggesting tubercular origin however, our study couldn't isolate the organism by culture.
A strongly positive tuberculin skin test result may increase the suspicion of tuberculous pericarditis, but a negative test does not exclude this diagnosis. 7 Only 13 patients in our study had positive tuberculin test positive. Mishra et al found that fluid PCR for Mycobacterium tuberculosis was positive in 74% of tuberculous effusions. The mean fluid ADA and Absolute Lymphocyte Count (ALC) values were significantly higher in tuberculous effusions than in non-tuberculous effusions. The sensitivity and specificity Nepalese Heart Journal 2018; 15(1): 35-38 of PCR, ADA (>38 IU/l) and ALC (>275/mm3) were 74% and 88%, 81% and 75%, and 90% and 83%, respectively, in diagnosing tuberculous effusions. 19 In our study, the ADA level and absolute lymphocyte count of tuberculous pericardial effusions were significant for the diagnosis but PCR was not done as it wasn't available within the center. Desai et al did a retrospective survey of 100 black patients with presumed tuberculous pericarditis showed 82 with pericardial effusion while 18 had constrictive pericarditis. The mortality rate was 17%. Of 82 with pericardial effusion, 15 developed constrictive pericarditis within 4 months, 16 died of cardiac tamponade. 20 Our study found that most common cardiac manifestation of tuberculosis was pericardial effusion followed by CCP and showed that despite antitubercular treatment pericardial effusion may progress to constriction.
In the developed countries, the HIV seropositivity is mainly the cause for TB pericarditis but in our study only one patient was seropositive for HIV. In country like ours, the reason is still the low economic condition so that even the younger patients suffer chronic constrictive pericarditis.
The potential benefit of corticosteroids is to quicken resolution of symptoms and decrease reaccumulation of fluid but didn't significantly affect the risk of death or progression to CCP. 21 After pericardiectomy, patients of CCP had good outcome except one patient who died immediately after the procedure. The favourable outcomes of antitubercular chemotherapy and timely pericardiectomy was seen in a study done by Yang CC et al . 22, 23 Conclusion:
Among all the extrapulmonary manifestations of TB, involvement of the heart is second only to central nervous system TB in terms of its devastating morbidity and mortality. Tuberculosis leads to any of the four clinical manifestations of tubercular pericarditis i.e acute pericarditis, effusive pericarditis, myopericarditis and CCP as well as myocarditis and aortitis. However it commonly manifests as pericarditis in developing countries like Nepal regardless of any age or gender. Since there is lack of improved techniques for recovery of M. tuberculosis such as PCR technology, pericardial IFN-g, biopsy, culture, we are still dependent only on 2D echo, ADA levels of pericardial fluid, supportive evidence of tuberculosis elsewhere in the body and clinical history of therapeutic response after anti tuberculosis chemotherapy. Had we got such sophisticated investigations done easily, the incidence of tuberculous pericarditis would have been assessed presumably better since early diagnosis and institution of appropriate therapy with antitubercular drugs are critical to prevent mortality.
